Table 3. Results of pooled hazard ratios for overall survival according to clinicopathological parameters.
Outcome | No. of patients | No. of studies | Combined results | Heterogeneity | Statistical Method | |||
---|---|---|---|---|---|---|---|---|
HR(95%CI) | p value | I2 (%) | P value | |||||
Age (>60 years) | 142 | 2 | 1.04 [0.30, 3.61] | 0.95 | 74 | 0.05 | Random model | |
Gender | 3559 | 6 | 1.03 [0.94, 1.13] | 0.51 | 34 | 0.18 | Fixed model | |
PD | 7157 | 6 | 2.19 [1.29, 3.70] | 0.003 | 93 | <0.00001 | Random model | |
positive margins | 4936 | 3 | 1.96 [1.71,2.24] | < .00001 | 0 | 0.54 | Fixed model | |
HTS | 317 | 3 | 1.72 [1.16, 2.57] | 0.007 | 0 | 0.6 | Fixed model | |
NLNI | 130 | 2 | 0.09 [0.04, 0.22] | < .00001 | 35 | 0.21 | Fixed model |
PD: poorly differentiation; HTS: high tumor stage; NLNI: no lymph nodes involved; HR: Hazard Ratio.